Dedicated to open source, inexpensive, scalable COVID screening

We’ve put together the technical, regulatory, and logistical pieces of a program that scales to testing millions of people frequently, reliably, and cheaply. Our approach combines:

Ultra-cheap test chemistry

Our test is fast and cost-effective but doesn’t compromise on reliability or sensitivity, unlike antigen testing.

Machine-free scaling

There are no specialized machines or instrumentation used for FloodLAMP—just basic lab equipment. This means testing can be massively scaled without the typical barriers and capital costs.

Distributed sample pooling

Enables collection of massive numbers of samples, with on-site and at-home pooling.

Open EUAs

The linchpin strategy—a path to regulatory priority and widespread adoption. We’re following in the footsteps of the first Open Protocol EUA, SalivaDirect.

Join our growing coalition of scientific collaborators, impact investors, corporate partners, and advocates in support of open source, universal COVID-19 testing.

Visual, instrument-free readout

Who we are

We are a Public Benefit Corporation dedicated to making the greatest positive impact on the COVID crisis and public health through a cooperative, open-science approach.

Open COVID Pledge

Immediate action is required to halt the COVID-19 Pandemic and treat those it has affected. It is a practical and moral imperative that every tool we have at our disposal be applied to develop and deploy technologies on a massive scale without impediment.

We therefore pledge to make our intellectual property available free of charge for use in ending the COVID-19 pandemic and minimizing the impact of the disease.

We will implement this pledge through a license that details the terms and conditions under which our intellectual property is made available.

Join us

We are actively recruiting mission-driven scientists, engineers, programmers, and generalists to join our fast-growing startup in San Carlos, CA. Both onsite and remote opportunities are available.